Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Ponatinib Market Status and Forecast (2017-2028)
  • 1.3.2 Global Ponatinib Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Ponatinib Supply by Company

• 2.1 Global Ponatinib Sales Volume by Company
• 2.2 Global Ponatinib Sales Value by Company
• 2.3 Global Ponatinib Price by Company
• 2.4 Ponatinib Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Ponatinib Market Status by Type

• 3.1 Ponatinib Type Introduction
  • 3.1.1 45mg
  • 3.1.2 15mg
• 3.2 Global Ponatinib Market by Type
  • 3.2.1 Global Ponatinib Sales Volume by Type (2017-2022)
  • 3.2.2 Global Ponatinib Sales Value by Type (2017-2022)
  • 3.2.3 Global Ponatinib Price by Type (2017-2022)
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Ponatinib Market Status by Application

• 4.1 Ponatinib Segment by Application
  • 4.1.1 CML
  • 4.1.2 ALL
• 4.2 Global Ponatinib Market by Application
  • 4.2.1 Global Ponatinib Sales Volume by Application (2017-2022)
  • 4.2.2 Global Ponatinib Sales Value by Application (2017-2022)
  • 4.2.3 Global Ponatinib Price by Application (2017-2022)
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Ponatinib Market Status by Region

• 5.1 Global Ponatinib Market by Region
  • 5.1.1 Global Ponatinib Sales Volume by Region
  • 5.1.2 Global Ponatinib Sales Value by Region
• 5.2 North America Ponatinib Market Status
• 5.3 Europe Ponatinib Market Status
• 5.4 Asia Pacific Ponatinib Market Status
• 5.5 Central & South America Ponatinib Market Status
• 5.6 Middle East & Africa Ponatinib Market Status

6 North America Ponatinib Market Status

• 6.1 North America Ponatinib Market by Country
  • 6.1.1 North America Ponatinib Sales Volume by Country (2017-2022)
  • 6.1.2 North America Ponatinib Sales Value by Country (2017-2022)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Ponatinib Market Status

• 7.1 Europe Ponatinib Market by Country
  • 7.1.1 Europe Ponatinib Sales Volume by Country (2017-2022)
  • 7.1.2 Europe Ponatinib Sales Value by Country (2017-2022)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Ponatinib Market Status

• 8.1 Asia Pacific Ponatinib Market by Country
  • 8.1.1 Asia Pacific Ponatinib Sales Volume by Country (2017-2022)
  • 8.1.2 Asia Pacific Ponatinib Sales Value by Country (2017-2022)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Ponatinib Market Status

• 9.1 Central & South America Ponatinib Market by Country
  • 9.1.1 Central & South America Ponatinib Sales Volume by Country (2017-2022)
  • 9.1.2 Central & South America Ponatinib Sales Value by Country (2017-2022)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Ponatinib Market Status

• 10.1 Middle East & Africa Ponatinib Market by Country
  • 10.1.1 Middle East & Africa Ponatinib Sales Volume by Country (2017-2022)
  • 10.1.2 Middle East & Africa Ponatinib Sales Value by Country (2017-2022)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Ponatinib Manufacturing Cost Analysis
• 11.5 Ponatinib Sales Channel and Distributors Analysis
  • 11.5.1 Ponatinib Sales Channel
  • 11.5.2 Ponatinib Distributors
• 11.6 Ponatinib Downstream Major Buyers

12 Global Ponatinib Market Forecast by Type and by Application

• 12.1 Global Ponatinib Sales Volume and Sales Value Forecast (2023-2028)
• 12.2 Global Ponatinib Forecast by Type
  • 12.2.1 Global Ponatinib Sales Volume Forecast by Type
  • 12.2.2 Global Ponatinib Sales Value Forecast by Type
  • 12.2.3 Global Ponatinib Price Forecast by Type
• 12.3 Global Ponatinib Forecast by Application
  • 12.3.1 Global Ponatinib Sales Volume Forecast by Application
  • 12.3.2 Global Ponatinib Sales Value Forecast by Application
  • 12.3.3 Global Ponatinib Price Forecast by Application

13 Global Ponatinib Market Forecast by Region/Country

• 13.1 Global Ponatinib Market Forecast by Region (2023-2028)
  • 13.1.1 Global Ponatinib Sales Volume Forecast by Region (2023-2028)
  • 13.1.2 Global Ponatinib Sales Value Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 ARIAD Pharmaceuticals
  • 14.1.1 Company Information
  • 14.1.2 Ponatinib Product Introduction
  • 14.1.3 ARIAD Pharmaceuticals Ponatinib Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
  • 14.1.4 SWOT Analysis

...

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Ponatinib market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Ponatinib industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Ponatinib market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Ponatinib Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Ponatinib market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Ponatinib Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Ponatinib industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
45mg
15mg

Segmented by Application
CML
ALL

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey